SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-117917
Filing Date
2017-04-10
Accepted
2017-04-10 14:05:56
Documents
5
Period of Report
2017-05-25
Effectiveness Date
2017-04-10

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d315604ddef14a.htm DEF 14A 351832
2 GRAPHIC g315604g62r17.jpg GRAPHIC 30086
3 GRAPHIC g315604g95j55.jpg GRAPHIC 8747
4 GRAPHIC g315604pc001.jpg GRAPHIC 184827
5 GRAPHIC g315604pc002.jpg GRAPHIC 107794
  Complete submission text file 0001193125-17-117917.txt   809782
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35420 | Film No.: 17752837
SIC: 2834 Pharmaceutical Preparations